CCL2 and atopic eczema: This aligns with previous studies demonstrating that IL-37b can inhibit the in vitro induction of pro-inflammatory cytokines (IL-6 and TNF-α) and chemokines (CXCL8, CCL2, and CCL5) related to atopic dermatitis.